Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

Slides:

Advertisements

Similar presentations

European Heart Journal 2010 European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic.

Advertisements

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC/HRS Guideline for the Management of.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC

Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Jean-François Tanguay, MD, CSPQ, FRCPC, FACC,

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,

171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and.

Values and Preferences of Physicians and Patients With Nonvalvular Atrial Fibrillation Who Receive Oral Anticoagulation Therapy for Stroke Prevention

No evidence that AF type significantly impacts stroke risk

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

Circ Cardiovasc Qual Outcomes

Role of the CHADS2 Score in Acute Coronary Syndromes

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

CHADS2 Score Predicts Postoperative Atrial Fibrillation in Patients Undergoing Elective Pulmonary Lobectomy Svetlana Kotova, MD, Mansen Wang, PhD, Katie.

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Implementation Ratika Parkash, MD, MSc, François Philippon,

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Laurent Macle, MD, John Cairns, MD, Kori.

2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. Executive summary

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization Manesh R. Patel, MD, FACC, Steven.

Mechanisms, Clinical Significance, and Prevention of Cognitive Impairment in Patients With Atrial Fibrillation Lena Rivard, MD, MSc, Paul Khairy, MD,

Developed in Collaboration With The American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology,

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Alan D. Bell, MD, CCFP, André Roussin, MD, FRCPC,

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice Jonathan G. Howlett, MD, FRCPC, Michael Chan, MBBS,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Left atrial appendage closure: A new technique for clinical practice

Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology,

Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease G.B. John Mancini, MD, Gilbert Gosselin,

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease Glenn N. Levine, MD, FACC, FAHA,

Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy Jean-François Tanguay, MD, CSPQ, FRCPC, FACC,

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures Gyorgy Frendl,

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines Laurent Macle, MD,

Self-Management of Anticoagulant Therapy in Mechanical Heart Valve Patients: A Matched Cohort Study Thomas Decker Christensen, MD, PhD, Flemming Skjøth,

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease Renato D. Lopes, MD, MHS, PhD, Meena Rao, MD,

The Extent of Left Atrial Low-Voltage Areas Included in Pulmonary Vein Isolation Is Associated With Freedom from Recurrent Atrial Arrhythmia Dong Huang,

CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation

Juan A. Crestanello, MD, Richard C. Daly, MD

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Atul Verma, MD, John A. Cairns, MD, L.

Volume 13, Issue 1, Pages 3-9 (January 2016)

Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation Kareem Bedeir, MBChB, MS, David R. Holmes, MD,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Systematizing Inpatient Referral to Cardiac Rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society Joint.

Optimizing Atrial Fibrillation Management

Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome Jonas Faxén, Hong Xu,

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Jason G. Andrade, MD, Atul Verma, MD,

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter Atul Verma, MD, FRCPC,

Volume 10, Issue 9, Pages (September 2013)

The Risk of Subsequent Atrial Fibrillation in Patients With Atrial Flutter: The Role of Conduction Abnormalities Reflected on the Surface Electrocardiogram

Association between the choice of anesthesia and in-hospital outcomes after carotid artery stenting Hanaa Dakour-Aridi, MD, Muhammad Rizwan, MD, Besma.

Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.

Canadian Cardiovascular Society/Canadian Cardiovascular Critical Care Society/Canadian Association of Interventional Cardiology Position Statement on.

Erratum Canadian Journal of Cardiology

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management Anne M. Gillis, MD, FRCPC, Atul Verma, MD, FRCPC, Mario.

Antithrombotic strategies in patients on long-term oral anticoagulation therapy undergoing percutaneous coronary intervention. ACS: acute coronary syndrome;

Rick A. Nishimura et al. JACC 2017;70:

Figure 8. Stroke prevention strategy in patients with AF

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Rehabilitation and Exercise and Surgical Coronary Revascularization

Figure 1. Decision-making process of stroke prevention in patients with AF from Asia. The decision-making process includes stroke risk evaluation, OAC.

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Mobile Medicine: Digital Dynamo or Virtual Vaporware

β-Blocker Use for the Stages of Heart Failure

Targeted Therapeutic Drug Monitoring for Direct Oral Anticoagulants: What Is Its Potential Place and Can It Limit Black Swan Events? D. George Wyse,

Presentation transcript:

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control Allan C. Skanes, MD, FRCPC, Jeff S. Healey, MD, MSc, FRCPC, John A. Cairns, MD, FRCPC, Paul Dorian, MD, FRCPC, Anne M. Gillis, MD, FRCPC, M. Sean McMurtry, MD, PhD, FRCPC, L. Brent Mitchell, MD, FRCPC, Atul Verma, MD, FRCPC, Stanley Nattel, MD, FRCPC Canadian Journal of Cardiology Volume 28, Issue 2, Pages 125-136 (March 2012) DOI: 10.1016/j.cjca.2012.01.021 Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 1 Summary of recommendations for antithrombotic agent use based on Congestive Heart Failure, Hypertension, Age > 75, Diabetes Mellitus, and Prior Stroke or Transient Ischemic Attack (CHADS2) score. Additional risk factors of age > 65, vascular disease, and female sex are integrated to increase granularity at low CHADS2 score (CHADS2 = 0). ASA, acetylsalicylic acid (aspirin); OAC, oral anticoagulant. Canadian Journal of Cardiology 2012 28, 125-136DOI: (10.1016/j.cjca.2012.01.021) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 2 A summary of our recommendations for antithrombotic management in settings of CAD. ACS, acute coronary syndrome; AF, atrial fibrillation; AFL, atrial flutter; ASA, acetylsalicylic acid (aspirin); CAD, coronary artery disease; CHADS2, Congestive Heart Failure, Hypertension, Age > 75, Diabetes Mellitus, and Prior Stroke or Transient Ischemic Attack; OAC, oral anticoagulant; PCI, percutaneous coronary intervention. Canadian Journal of Cardiology 2012 28, 125-136DOI: (10.1016/j.cjca.2012.01.021) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 3 Summary of recommendations for choice of rate-control agents for various conditions. CAD, coronary artery disease; CCB, calcium channel blocking agents; Rx, therapy. Canadian Journal of Cardiology 2012 28, 125-136DOI: (10.1016/j.cjca.2012.01.021) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 4 Summary of recommendations for choice of rhythm-control therapy in patients with normal systolic left ventricular function and no history of congestive heart failure. AV, atrioventricular; CAD, coronary artery disease; CHF, congestive heart failure; Hx, history; VT, ventricular tachycardia. Canadian Journal of Cardiology 2012 28, 125-136DOI: (10.1016/j.cjca.2012.01.021) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 5 Summary of recommendations for choice of rhythm-control therapy in patients with a history of congestive heart failure (current or remote) or left ventricular systolic dysfunction. CHF, congestive heart failure; EF, ejection fraction; Hx, history; VT, ventricular tachycardia. Canadian Journal of Cardiology 2012 28, 125-136DOI: (10.1016/j.cjca.2012.01.021) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions